Free cookie consent management tool by TermsFeed

ESGAR proudly presents the


Hepatocellular Carcinoma (HCC)

Join us on November 8!

Registration is free of charge and is open now!

Register Now!


November 8, 2024


Hepatocellular Carcinoma (HCC)

Organised by ESGAR and it's affiliated societies:

Organising Committee 

Dr. Damian Tolan, Leeds, United Kingdom
Organising Committee Chair

Prof. Giuseppe Brancatelli, Palermo, Italy
Scientific Coordinator     

Prof. Valerie Vilgrain, Clichy, France
Scientific Coordinator  

Dr. Marc Zins, Paris, France
ESGAR President

Live Streaming

The virtual forum will be live streamed in a Zoom Webinar format. The session times are CET (Central European Time).

The forum will be broadcast live from 12:00 noon to 18:00 CET, featuring live translations and subtitles in Spanish and French.


This forum represents a noteworthy collaborative effort between ESGAR and its affiliated societies in Asia (ASAR), Australia/New Zealand (ARGANZ), and North America (SAR), aimed at advancing the field of Radiology.

This one-day global virtual event is dedicated to Hepatocellular Carcinoma (HCC), the commonest abdominal malignancy. The agenda encompasses a comprehensive exploration of HCC, including discussions on its global impact and burden, pathophysiology, multimodality imaging assessment for screening, staging, and treatment response evaluation, as well as systemic and interventional radiology image-guided therapies. Distinguished speakers from all five continents will contribute to deepening your understanding of abdominal imaging and foster a spirit of international collaboration among radiologists to improve the lives of patients, as detailed in the programme.


November 8, 2024

12:00 – 13:00      

Session 1: The Worldwide Burden of Hepatocellular Carcinoma

Moderators: Damian Tolan, Leeds/UK;
Mark Goodwin, Melbourne/AU

12:00 – 12:10The global burden of HCC: International trends and perspectives

Catherine de Martel, WHO, Geneva/CH

12:10 – 12:20Barriers to implementation and access to care

Danjuma K. Adda, WHA, NG

12:20 – 12:30Screening and surveillance for HCC: Who, when and how

Valérie Vilgrain, Clichy/FR

12:30 – 12:40Hepatocarcinogenesis and molecular characterisation of HCC: Rad-path correlation

Jessica Yang, Sydney/AU

12:40 – 12:50

The role of diagnostic and interventional radiologists in the multidisciplinary meetings

James Seow, Perth/AU

12:50 – 13:00Discussion 
13:30 – 14:30        Session 2: Optimising multi-modality imaging in liver disease (Ultrasound, CT and MRI)

Moderators: Cher Heng Tan, Singapore/SG;
Giuseppe Brancatelli, Palermo/IT

13:30 – 13:42Liver imaging: Optimising my Ultrasound approach

Paul Sidhu, London/UK

13:42 – 13:54Liver imaging: Optimising my CT protocol

Daniella Braz Parente, Rio de Janeiro/BR

13:54 – 14:06Liver imaging: Optimising my MRI protocols

Frank Miller, Chicago, IL/US

14:06 – 14:18Liver imaging: Quantification techniques

Manuela França, Porto/PT

14:10 – 14:30Discussion 

15:00 – 16:00

Session 3: Diagnosis and staging of hepatocellular carcinoma

Moderators: Marc Zins, Paris/FR;
Bin Song, Chengdu/CN

15:00 – 15:12

Diagnosis and staging of hepatocellular carcinoma: Western guidelines

Christoph J. Zech, Basel/CH

15:12 – 15:24Diagnosis and staging of hepatocellular carcinoma: Eastern guidelines

Jeong Min Lee, Seoul/KR

15:24 – 15:36Ultrasound and CEUS for HCC diagnosis – my 3 top points

Stephanie Wilson, Calgary, AB/CA

15:36 – 15:48How to use CT/MRI LI-RADS: Looking backward to look forward

Victoria Chernyak, New York, NY/US

15:48 – 16:00Discussion 

16:30 – 17:30       

Session 4: Additional key imaging concepts in HCC management

Moderators: Alice W. Fung, Portland, OR/US;
Kate McLean, Brisbane/AU

16:30 – 16:40

How to deal with premalignant lesions in daily practice: A case-based session

Maxime Ronot, Clichy/FR

16:40 – 16:50Interventional radiology and image-guided treatments for HCC

Charles Sanyika, Johannesburg/ZA

16:50 – 17:00Systemic therapy in advanced HCC: What every radiologist needs to know

Bachir Taouli, New York, NY/US

17:00 – 17:10

Evaluating treatment response in HCC

Jin Wang, Guangzhou/CN

17:10 – 17:20CT/MRI v2024 and CEUS v2024 treatment response assessment: What’s new in LI-RADS?

Claude Sirlin, San Diego, CA/US

17:20 – 17:30Discussion 



To overcome geographical and economic barriers in medical education, the programme from the leading international experts is free of charge for all participants.

Register now


Danjuma K. Adda
World Hepatitis Alliance (WHA)
James Seow
Royal Perth Hospital
Perth, Australia
Giuseppe Brancatelli
University of Palermo
Palermo, Italy
Paul Sidhu
King's College London
London, United Kingdom
Victoria Chernyak
Memorial Sloan Kettering Cancer Center
New York, NY, United States of America
Claude Sirlin
University of California
San Diego, CA, United States of America
Catherine de Martel
World Health Organisation (WHO)
Geneva, Switzerland
Bin Song
West China Hospital Sichuan University
Chengdu, China
Manuela França
Centro Hospitalar do Porto
Porto, Portugal
Cher Heng Tan
Tan Tock Seng Hospital
Alice W. Fung
Oregon Health & Science University
Portland, OR, United States of America
Bachir Taouli
Mount Sinai Hospital
New York, NY, United States of America
Mark Goodwin
Austin Health
Melbourne, Australia
Damian Tolan
Leeds Teaching Hospital NHS
Leeds, United Kingdom
Jeong Min Lee
Seoul National University Hospital
Seoul, South Korea
Valerie Vilgrain
Hôpital Beaujon
Clichy, France
Kate McLean
Princess Alexandra Hospital
Brisbane, Australia
Jin Wang
Jinan University
Guangzhou, China
Frank Miller
Northwestern University
Chicago, IL, United States of America
Stephanie Wilson
University of Calgary
Calgary, AB, Canada
Daniella Parente
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Jessica Yang
Macquarie University Hospital and St Vincent's Private Hospital
Sydney, Australia
Maxime Ronot
Hôpital Beaujon
Clichy, France
Christoph Johannes Zech
University Hospital Basel
Basel, Switzerland
Charles Sanyika
Wits University Donald Gordon Medical Centre
Johannesburg, Gauteng, South Africa
Marc Zins
Hôpital Saint Joseph
Paris, France

Join us on November 8!

Registration is free of charge and is open now!